How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 62, Issue 7, Pages 919-926
Publisher
Oxford University Press (OUP)
Online
2016-01-12
DOI
10.1093/cid/civ1222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Hepatitis C in HIV-Infected Patients: Moving Towards an Era of All Oral Regimens
- (2015) Ting-Yi Chen et al. AIDS PATIENT CARE AND STDS
- Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
- (2015) Soumitri Barua et al. ANNALS OF INTERNAL MEDICINE
- Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1
- (2015) Mark S. Sulkowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study
- (2015) Jean-Michel Molina et al. LANCET
- Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
- (2015) Susanna Naggie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1
- (2015) David L. Wyles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial
- (2015) Jürgen K Rockstroh et al. Lancet HIV
- Factors influencing adherence in Hepatitis-C infected patients: a systematic review
- (2014) Tim Mathes et al. BMC INFECTIOUS DISEASES
- Simeprevir (TMC435) With Pegylated Interferon/Ribavirin in Patients Coinfected With HCV Genotype 1 and HIV-1: A Phase 3 Study
- (2014) Douglas Dieterich et al. CLINICAL INFECTIOUS DISEASES
- Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
- (2014) Mark S. Sulkowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
- (2014) Michael Manns et al. LANCET
- Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
- (2014) Ira M Jacobson et al. LANCET
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV
- (2014) Peter Ferenci et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
- (2014) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality
- (2013) MB Klein et al. HIV MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment Outcomes of Treatment-Naïve Hepatitis C Patients Co-Infected with HIV: A Systematic Review and Meta-Analysis of Observational Cohorts
- (2013) Anna Davies et al. PLoS One
- Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era
- (2012) Vincent Soriano et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Relationship of Liver Disease Stage and Antiviral Therapy With Liver-Related Events and Death in Adults Coinfected With HIV/HCV
- (2012) Berkeley N. Limketkai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
- (2009) Margaret Hellard et al. CLINICAL INFECTIOUS DISEASES
- Cohort Profile: The Canadian HIV-Hepatitis C Co-infection Cohort Study
- (2009) M. B. Klein et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study
- (2009) Dominique Salmon-Ceron et al. JOURNAL OF HEPATOLOGY
- The Challenge of Hepatitis C in the HIV-Infected Person
- (2008) David L. Thomas Annual Review of Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started